bibliographic entry 12498250 [be/12498250]
https://w3id.org/oc/corpus/be/12498250

is a

• bibliographic reference

content

• Herter, S, Herting, F, Mundigl, O, Waldhauer, I, Weinzierl, T, Fauti, T. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol Cancer Ther (2013) 12: 2031–42. DOI: 10.1158/1535-7163.MCT-12-1182 PMID: 23873847

references

• https://w3id.org/oc/corpus/br/2532894